Wealthspire Advisors LLC lessened its holdings in Danaher Co. (NYSE:DHR – Free Report) by 3.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,541 shares of the conglomerate’s stock after selling 149 shares during the period. Wealthspire Advisors LLC’s holdings in Danaher were worth $1,042,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter worth approximately $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC bought a new stake in Danaher in the fourth quarter valued at $31,000. Strategic Financial Concepts LLC acquired a new position in Danaher during the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC lifted its holdings in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 57 shares during the period. Institutional investors own 79.05% of the company’s stock.
Insider Buying and Selling at Danaher
In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 11.10% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Stock Analysis on DHR
Danaher Stock Down 0.2 %
Shares of NYSE:DHR opened at $210.65 on Wednesday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market cap of $150.56 billion, a price-to-earnings ratio of 39.90, a P/E/G ratio of 2.66 and a beta of 0.83. The company has a 50 day moving average of $225.79 and a 200-day moving average of $246.04. Danaher Co. has a one year low of $196.80 and a one year high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last released its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the firm posted $2.09 earnings per share. On average, sell-side analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. This is an increase from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio is currently 24.24%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- The 3 Best Blue-Chip Stocks to Buy Now
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Technology Stocks Explained: Here’s What to Know About Tech
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Ride Out The Recession With These Dividend Kings
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.